Latest disclosed round
Series B
- Date
- 2026-05-01
- Amount
- USD 600m
- Sector
- AI / ML / data; Biotech & techbio
- Companies House
- 13223825
Series B
Isomorphic Labs
AI drug discovery / computational biology; AI drug discovery / foundation models
CandidateSeries BLondon
Evidence status
Review retained
- Identity
- Candidate
- Match
- High candidate
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
7 linked investors
Funding record
1 disclosed round
| Date | Stage | Amount | Investors |
|---|---|---|---|
| 2026-05-12 | Series B | $2.1B | Thrive Capital, Alphabet, GV, MGX, Temasek, CapitalG, UK Sovereign AI Fund |
Traceability
Source trail
Funding and investor claims retain their public-source links. This is a research snapshot, not a live cap table.